- B2B
- Scale StageRapidly increasing operations
- Top InvestorsThis company has received a significant amount of investment from top investors
Accelerating impact through partnerships
- $135k – $240k
- |
- |5 years of exp
- |Full Time
About the job
At Inceptive, you will drive development forward that could help billions of people. To accomplish this, you will be part of a collaborative, antedisciplinary team building our biological software.We are looking for an exceptional and motivated individual to join our business development team.You will be joining a dynamic and agile team, set to execute on our mission and capitalize on scientific, business, and strategic opportunities. We are seeking an Alliance Manager to lead and grow our strategic partnerships in oligonucleotide therapeutics, with a primary focus on small interfering RNA (siRNA) drug discovery. As a key member of our Business Development team, you will serve as the primary interface between our company and our external partners — spanning pharmaceutical companies, academic institutions, and technology providers — ensuring alliances are structured for scientific success and commercial value.This role sits at the intersection of cutting-edge AI-driven biology and next-generation RNA therapeutics. You will leverage our proprietary AI platform to identify, establish, and manage high-impact collaborations that accelerate the development of siRNA-based medicines.Your mission, should you choose to accept itEmbody our vision of an antedisciplinary environment and embrace learning about areas outside of your traditional area of expertiseServe as the primary point of contact for existing siRNA and oligonucleotide partnerships, managing day-to-day alliance operations and escalation pathwaysEstablish and lead Joint Steering Committees (JSCs), Joint Research Committees (JRCs), and other governance bodies, preparing agendas, minutes, and action trackingMonitor contractual milestones, deliverables, and timelines; proactively identify and resolve issues that could jeopardize partnership successCoordinate cross-functional internal teams (Biology, Chemistry, AI/ML, Regulatory, Legal, Finance) to fulfill partner obligations and advance shared programsDrive successful execution of partnered programs against scientific and operational milestones and enable expansion opportunities across strategic partnershipsPrepare documents and presentations to senior management to help drive decision-making through the deal processTravel to industry events, scientific or business orientedScientific & Strategic EngagementDevelop a deep understanding of partner pipelines, strategic priorities, and siRNA platform capabilities to align collaboration goalsTranslate AI platform outputs and siRNA design insights into compelling partnership narratives for both scientific and business audiencesCollaborate with internal discovery teams to ensure partner-facing scientific deliverables meet alliance commitmentsStay current on competitive landscape in RNAi therapeutics, GalNAc-siRNA conjugates, lipid nanoparticle (LNP) delivery, and AI-driven target discoveryQualificationsPh.D. or M.S. in Molecular Biology, Biochemistry, Pharmacology, or a related life sciences field; MBA a plus5+ years of experience in alliance management, business development, or strategic partnerships within the biopharmaceutical or biotech industryWorking knowledge of oligonucleotide therapeutics — particularly siRNA biology, mechanism of action, and drug development challengesDemonstrated experience managing complex, multi-party research or licensing collaborations from initiation through program deliveryExceptional interpersonal, negotiation, and communication skills; ability to influence without direct authority across internal and external stakeholdersStrong project management skills with proficiency in tools such as Linear, Notion, or equivalent platformsFamiliarity with AI/ML applications in drug discovery, including sequence-based target identification or predictive ADME/toxicity modelingPrior experience negotiating term sheets, CDAs, MTAs, or master research collaboration agreementsExisting network within the oligonucleotide therapeutics ecosystem (pharma, biotech, CRO, and academic partners)Availability to accommodate working with team members across different time zones, with one or two meetings per week starting at 7am PT or finishing at 7pm CETReadiness to travel several times a year for company retreats and business eventsWe value the benefits of in-person collaboration and expect candidates to primarily work at our office locations
About the company
- B2B
- Scale StageRapidly increasing operations
- Top InvestorsThis company has received a significant amount of investment from top investors
Similar Jobs









